FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • November 8th, 2011 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS FIRST AMENDMENT TO LICENSE AGREEMENT (the “Amendment”) is made and entered into as of August 31, 2011 (“Amendment Effective Date”) and amends the License Agreement effective as of January 6, 2011 (the “Agreement”) by and between Ligand Pharmaceuticals Incorporated, a corporation organized under the laws of Delaware (“Ligand”), and Chiva Pharmaceuticals, Inc., a corporation organized under the laws of the Cayman Islands (“Chiva”).
November 1, 2011 John Sharp Chief Financial Officer LIGAND PHARMACEUTICALS, INC. 11085 N. Torrey Pines Road San Diego, CA 92121 RE: CONFIRMATION OF SHORT- TERM LEASE EXTENSION Dear John: Please allow this letter to serve as confirmation of a...Ligand Pharmaceuticals Inc • November 8th, 2011 • Pharmaceutical preparations
LICENSE AGREEMENTLicense Agreement • November 8th, 2011 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
This LICENSE AGREEMENT (the “Agreement”) is executed as of October 7, 2011 (the “Effective Date”) by and between Ligand Pharmaceuticals Incorporated, a corporation organized under the laws of Delaware and having a place of business at 11085 North Torrey Pines Road, Suite 300, La Jolla, CA, 92037 (“Ligand”) and Chiva Pharmaceuticals, Inc. a corporation organized under the laws of the Cayman Islands whose registered office is situated at Scotia Centre, 4th Floor, P.O. Box 2804, George Town, Grand Cayman KY1-1112, Cayman Islands (“Chiva”). Ligand and Chiva are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.”
LICENSE AGREEMENTCommercial License Agreement • November 8th, 2011 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
*** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
